SecSonar.com

Prenetics Global Limited (PRE)

Prenetics Global Limited at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

Prenetics Global Limited (PRE) is a Medical - Diagnostics & Research company based in HK with a market capitalization of $360.1M. Revenue grew 201.7% year-over-year and free cash flow was negative at -$22M. This page tracks PRE's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

HK · 285 employees · IPO Jul 16, 2021

Valuation

Valuation & price

$15.61 · as of May 17, 2026 · -29.5% vs 52w high

—

P/E ratio

Latest-FY diluted EPS

2.06

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$21.97$14.63$7.29Jul 25Dec 25Jul 26Jul 7, 25$8.01Jul 9, 25$8.08Jul 11, 25$7.89Jul 15, 25$8.25Jul 17, 25$8.06Jul 21, 25$8.07Jul 23, 25$8.63Jul 25, 25$8.06Jul 29, 25$8.01Jul 31, 25$8.07Aug 4, 25$7.82Aug 6, 25$7.88Aug 11, 25$8.00Aug 13, 25$7.65Aug 15, 25$7.60Aug 19, 25$7.72Aug 21, 25$7.29Aug 25, 25$7.33Aug 27, 25$7.40Aug 29, 25$7.62Sep 3, 25$8.10Sep 5, 25$8.09Sep 9, 25$9.30Sep 11, 25$8.86Sep 16, 25$9.49Sep 18, 25$10.84Sep 22, 25$12.39Sep 24, 25$13.70Sep 26, 25$12.57Sep 30, 25$13.30Oct 2, 25$15.06Oct 6, 25$14.98Oct 8, 25$14.81Oct 10, 25$13.89Oct 14, 25$13.99Oct 16, 25$15.86Oct 21, 25$16.54Oct 23, 25$17.38Oct 27, 25$13.08Oct 29, 25$13.82Oct 31, 25$14.82Nov 4, 25$12.81Nov 6, 25$12.35Nov 10, 25$11.89Nov 12, 25$13.87Nov 14, 25$12.20Nov 18, 25$12.32Nov 20, 25$12.88Nov 25, 25$15.31Nov 28, 25$14.55Dec 2, 25$14.14Dec 4, 25$13.93Dec 8, 25$14.32Dec 10, 25$14.30Dec 12, 25$14.86Dec 16, 25$16.58Dec 18, 25$16.49Dec 22, 25$18.38Dec 24, 25$16.91Dec 29, 25$16.28Jan 2, 26$15.78Jan 6, 26$16.30Jan 8, 26$16.75Jan 12, 26$15.83Jan 14, 26$15.72Jan 16, 26$15.72Jan 21, 26$16.37Jan 23, 26$18.42Jan 27, 26$19.29Jan 29, 26$20.48Feb 2, 26$19.41Feb 4, 26$18.93Feb 9, 26$21.12Feb 11, 26$21.40Feb 13, 26$21.97Feb 18, 26$20.06Feb 20, 26$17.05Feb 24, 26$15.90Feb 26, 26$17.81Mar 2, 26$15.84Mar 4, 26$15.38Mar 6, 26$17.80Mar 10, 26$19.94Mar 12, 26$20.78Mar 17, 26$20.73Mar 19, 26$21.15Mar 23, 26$21.46Mar 25, 26$21.56Mar 27, 26$20.50Mar 31, 26$19.32Apr 2, 26$19.68Apr 7, 26$19.10Apr 9, 26$17.47Apr 13, 26$18.17Apr 15, 26$17.75Apr 17, 26$17.83Apr 22, 26$17.96Apr 24, 26$18.33Apr 28, 26$18.38Apr 30, 26$16.71May 4, 26$16.50May 6, 26$15.90May 8, 26$16.16May 12, 26$17.99May 14, 26$17.59May 18, 26$14.54May 20, 26$15.47May 22, 26$16.77May 28, 26$20.18Jun 1, 26$20.39Jun 3, 26$20.83Jun 5, 26$19.86Jun 9, 26$20.93Jun 11, 26$20.69Jun 15, 26$20.75Jun 17, 26$19.86Jun 22, 26$19.96Jun 24, 26$19.72Jun 26, 26$18.83Jul 2, 26$16.93
$7.2552-week range$22.15
Loading valuation history…

Fundamentals

Key fundamentals

$360.1M

Market cap

201.7%

Revenue growth (YoY)

52.8%

Gross margin

-$22M

Free cash flow (USD)

-$59.3M

Net debt

Net cash position

10.6%

Share dilution

2/5

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2019 → 2025

FY 2019$9.2MFY 2020$65.2MFY 2021$12.5MFY 2022$13.2MFY 2023$21.7MFY 2024$30.6MFY 2025$92.4M
$9.2M$92.4M

Free cash flow by year

2019 → 2025

FY 2019$-2.3MFY 2020$-5.9MFY 2021$2.0MFY 2022$8.2MFY 2023$-14.7MFY 2024$-29.9MFY 2025$-22.0M
-$2.3M-$22M

Gross margin by year

2021 → 2025

FY 202128.8%FY 202227.5%FY 202340.6%FY 202450.3%FY 202552.8%
28.8%52.8%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

0

Insider buys · 90 days

0

Insider sells · 90 days

Earnings

Last reported: Jun 10, 2026 (EPS $-0.56)

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • Annual report20-F FiledJul 2, 2026Filing
  • Annual reportAnnual Report FiledJun 10, 2026Filing
  • 6-K filingManagement ChangeJun 4, 2026Filing
  • 6-K filingPartnership AnnouncementMay 20, 2026Filing
  • Annual reportAnnual Report FiledMay 14, 2026Filing
  • 6-K filingManagement ChangeMay 14, 2026Filing
  • 6-K filingStrategic PartnershipMay 7, 2026Filing
  • Annual reportAnnual Report FiledMay 4, 2026Filing
  • Annual report20-F FiledApr 30, 2026Filing
  • 6-K filingPartnership AnnouncementApr 2, 2026Filing

Questions

Frequently asked questions

What is Prenetics Global Limited's market cap?

Prenetics Global Limited (PRE) has a market capitalization of $360.1M.

What is PRE's P/E ratio?

A meaningful P/E ratio is not available for PRE — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.

What is PRE's price-to-book (P/B) ratio?

PRE trades at 2.06 times book value per share.

When did Prenetics Global Limited last report earnings?

PRE last reported earnings on June 10, 2026; the next date is not yet scheduled.

Are insiders buying PRE stock?

SEC Form 4 filings show no open-market insider buys at Prenetics Global Limited in the last 90 days (0 sells).

Same arena

Related companies in Medical - Diagnostics & Research

MYGN

Myriad Genetics, Inc.

$378.3M

NEO

NeoGenomics, Inc.

$276.4M

FLGT

Fulgent Genetics, Inc.

$528.9M

IMDX

Insight Molecular Diagnostics Inc.

$173.1M

BDSX

Biodesix, Inc.

$129.6M

ATLN

Atlantic International Corp.

$122.2M

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.